Verve Therapeutics (VERV) Stock Chart & Stock Price History $7.28 -0.55 (-7.02%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$7.44 +0.15 (+2.13%) As of 02/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Verve Therapeutics Stock Price Performance 5 Day Performance-15.15%1 Month Performance-6.67%3 Month Performance+50.10%6 Month Performance+50.41%Year-To-Date Performance+29.08%1 Year Performance-45.35% Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address VERV Stock Chart for Saturday, February, 22, 2025 VERV Chart by TradingView Verve Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$7.83$7.28-7.02%$8.02$7.021.18 million shs$616.33 million02/20/2025$8.07$7.83-2.97%$8.06$7.651.06 million shs$662.89 million02/19/2025$8.48$8.07-4.83%$8.52$7.861.11 million shs$683.21 million02/18/2025$8.58$8.48-1.17%$9.31$8.311.58 million shs$717.92 million02/17/2025$8.58$8.58$8.87$7.821.41 million shs$726.42 million02/14/2025$7.71$8.58+11.28%$8.87$7.821.41 million shs$726.38 million02/13/2025$8.04$7.71-4.10%$8.22$7.541.08 million shs$652.76 million02/12/2025$7.81$8.04+2.94%$8.05$7.44777,745 shs$680.67 million02/11/2025$7.98$7.81-2.13%$8.00$7.62831,803 shs$661.20 million02/10/2025$8.16$7.98-2.21%$8.26$7.651.63 million shs$675.59 million Get the Latest News and Ratings for VERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$8.36$8.16-2.39%$8.52$8.061.07 million shs$690.83 million02/06/2025$8.63$8.36-3.13%$8.77$8.181.38 million shs$707.76 million02/05/2025$8.06$8.63+7.07%$8.77$8.151.93 million shs$730.62 million02/04/2025$7.52$8.06+7.18%$8.22$7.572.20 million shs$682.36 million02/03/2025$7.61$7.52-1.18%$7.57$6.951.30 million shs$636.64 million01/31/2025$7.41$7.61+2.70%$7.90$7.381.29 million shs$644.26 million01/30/2025$7.70$7.41-3.77%$7.96$7.391.14 million shs$627.33 million01/29/2025$7.25$7.70+6.21%$7.98$7.251.04 million shs$651.88 million01/28/2025$7.76$7.25-6.57%$7.65$7.001.38 million shs$613.79 million01/27/2025$7.91$7.76-1.90%$8.05$7.611.27 million shs$656.99 million01/24/2025$7.99$7.91-1.00%$8.54$7.812.25 million shs$669.66 million01/23/2025$7.80$7.99+2.44%$8.70$7.713.87 million shs$676.43 million01/22/2025$6.57$7.80+18.72%$8.00$6.624.66 million shs$660.35 million01/21/2025$6.14$6.57+7.00%$6.90$6.152.13 million shs$556.22 million Related Companies Edgewise Therapeutics Stock Chart Arrowhead Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart Mirum Pharmaceuticals Stock Chart Gemini Therapeutics Stock Chart Mesoblast Stock Chart ImmunityBio Stock Chart Centessa Pharmaceuticals Stock Chart HUTCHMED Stock Chart Kymera Therapeutics Stock Chart Receive VERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VERV) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verve Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Verve Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
